281 related articles for article (PubMed ID: 3839826)
1. Immunomodulation with corticosteroids and levamisole in leprosy as gauged by in vivo lepromin and in vitro CMI responses.
Kundu SK; Hazra SK; Chaudhuri SK; Nandy A
Indian J Lepr; 1985; 57(1):37-57. PubMed ID: 3839826
[TBL] [Abstract][Full Text] [Related]
2. The in vivo and in vitro effects of levamisole in patients with lepromatous leprosy.
Sher R; Wadee AA; Joffe M; Kok SH; Imkamp FM; Simson IW
Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):159-66. PubMed ID: 7196885
[TBL] [Abstract][Full Text] [Related]
3. DNCB contact sensitization in leprosy: its comparison with other CMI tests.
Jayasingh K; Bhatia VN
Indian J Lepr; 1984; 56(2):207-11. PubMed ID: 6548491
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies on the effect of levamisole in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Feb; 13(2):93-6. PubMed ID: 6374154
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids and lepromin sensitivity.
Kundu SK; Hazra SK; Ghosh S; Chaudhuri S
Lepr India; 1982 Jul; 54(3):489-98. PubMed ID: 7176537
[TBL] [Abstract][Full Text] [Related]
6. Immuno-stimulatory effect of levamisole in borderline leprosy cases.
Arora SK; Singh G; Sen PC
Indian J Lepr; 1985; 57(1):22-6. PubMed ID: 3839822
[TBL] [Abstract][Full Text] [Related]
7. Lepromin-induced suppressor cells in patients with leprosy.
Mehra V; Mason LH; Fields JP; Bloom BR
J Immunol; 1979 Oct; 123(4):1813-7. PubMed ID: 158056
[TBL] [Abstract][Full Text] [Related]
8. [Cell mediated immunity in a group of lepers (leukocytes migration inhibition test)].
García González J; Diáz Almeida J; Mayea Milián L; de la Cruz Castillo F
Rev Cubana Med Trop; 1978; 30(2):53-8. PubMed ID: 368912
[TBL] [Abstract][Full Text] [Related]
9. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
[TBL] [Abstract][Full Text] [Related]
10. Effect of levamisole therapy on lepromin reaction in lepromatous leprosy cases.
Arora SK; Singh G; Sen PC
Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):113-4. PubMed ID: 3998557
[No Abstract] [Full Text] [Related]
11. Failure of levamisole to alter the lepromin reaction.
Meyers WM; Kvernes S; Staple EM
Am J Trop Med Hyg; 1975 Sep; 24(5):857-9. PubMed ID: 1103643
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cell mediated immunity in healthy contacts of leprosy.
Kurhade AM; Akulwar SL; Pathak AA; Thakar YS; Dhanvijay AG
Indian J Pathol Microbiol; 1996 Jul; 39(3):197-201. PubMed ID: 8972148
[TBL] [Abstract][Full Text] [Related]
13. Serum factors affecting the cell migration inhibition response to lepromin.
Fliess EL; Ruibal-Ares B; Braun M
Int J Lepr Other Mycobact Dis; 1975; 43(4):320-6. PubMed ID: 1241688
[TBL] [Abstract][Full Text] [Related]
14. Preliminary trial of intervention levamisole therapy in persistently bacteriologically positive lepromatous leprosy.
Ramu G; Sengupta U
Lepr India; 1983 Jan; 55(1):64-7. PubMed ID: 6876762
[TBL] [Abstract][Full Text] [Related]
15. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
[TBL] [Abstract][Full Text] [Related]
16. The granulomatous response of leprosy patients to lepromin and killed BCG.
Han SH; Kuo SL; Hu SC; Lu ST
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Jun; 13(2):121-7. PubMed ID: 7004801
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte blastogenesis and lepromin reactivity in leprosy patients and their parents.
Foss NT; Pagnano PM; Bechelli LM; Simoes AL
Acta Leprol; 1990; 7(2):119-28. PubMed ID: 2220296
[TBL] [Abstract][Full Text] [Related]
18. Variable lepromin response to Mycobacterium leprae in resistant armadillos.
Job CK; Kirchheimer WF; Sanchez RM
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):347-53. PubMed ID: 6685696
[TBL] [Abstract][Full Text] [Related]
19. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
[TBL] [Abstract][Full Text] [Related]
20. [Cellular immunity in leprosy patients].
de Arruda MS; de Arruda OS; Fleury RN; Garcia Dde O; Opromolla DV; Ura S
Med Cutan Ibero Lat Am; 1982; 10(4):231-8. PubMed ID: 6763656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
